← All peptidesPDA-V1 attestation Citations
warningBioGate · AMBERGrade B
Nesiritide (BNP, Natrecor)
SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRHRecombinant human BNP; binds NPR-A to elevate cGMP, drive vasodilation, natriuresis, and reduce filling pressures.
disulfide C10-C2632-residue B-type natriuretic peptide
MW
3464.00
Length
32aa
Posterior
81.2%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · disulfide C10-C26
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 1
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
4
Participants
343
Mean Δ
+7.13
Δ HRV ms (8-week) · 95% CI [5.44, 8.82]
IPNFT - Not minted
This peptide is not currently represented as an IPNFT. Cohort outcomes feed back into the unminted pool.
Source literature.
Grade A2000 · N Engl J Med
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated CHF
Colucci WS et al.